Dispensing of generically equivalent drug product or interchangeable biological product.
Effective Oct 20, 2020Sept. 10, 1976, D.C. Law 1-81, title III, § 302, 23 DCR 2460; Apr. 7, 1977, D.C. Law 1-114, § 4(a), 23 DCR 8743; Mar. 11, 2010, D.C. Law 18-118, § 2(b), 57 DCR 901; Oct. 20, 2020, D.C. Law 23-133, § 2(c)
(a)
- (1) When a pharmacist receives a prescription for a brand name drug, the pharmacist may dispense a generically equivalent drug product or interchangeable biological product that is listed in the Orange Book; provided, that the pharmacist shall dispense a generically equivalent drug product or interchangeable biological product if requested by the purchaser, except as provided in § 48-803.03.
- (2) If a generic substitution is made pursuant to this subsection, the pharmacist shall dispense the generically equivalent drug product or interchangeable biological product in stock having the lowest cost to the person purchasing the drug product.
- (b) When a pharmacist receives a prescription for a drug by generic name or interchangeable biological product, the pharmacist shall dispense the listed product in stock that has the lowest cost to the person purchasing the drug product.
- (c) Repealed.
History
Sept. 10, 1976, D.C. Law 1-81, title III, § 302, 23 DCR 2460
Apr. 7, 1977, D.C. Law 1-114, § 4(a), 23 DCR 8743
Mar. 11, 2010, D.C. Law 18-118, § 2(b), 57 DCR 901
Oct. 20, 2020, D.C. Law 23-133, § 2(c)
Effect of Amendments
D.C. Law 18-118 rewrote the section.
Prior Codifications
1973 Ed., § 33-832.
1981 Ed., § 33-732.
Section References
This section is referenced in § 48-803.03 and § 48-803.05.